ArticleTranslational lung cancer research2025
Enhancing the intraoperative identification of high-grade patterns in invasive lung adenocarcinoma via radiomics.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-grade patterns (HGPs) are important for surgical decision-making in patients with invasive lung adenocarcinoma (IAC), but the sensitivity of intraoperative frozen section (FS) is not high. Radiomics has the potential to improve the sensitivity of intraoperative detection. The purpose of the present study was to evaluate the value of combining radiomics with FS analysis for predicting HGPs in patients with clinical T1 (cT1) IAC. Methods: Data from a total of 490 patients who were surgically diagnosed with IAC from January 2019 to April 2019 were retrospectively analyzed; the patients were randomly divided into a training set (n=392) and a test set (n=98). The presence of HGPs (micropapillary, solid, and complex glandular patterns) was evaluated according to the final pathology (FP). Radiomics features were extracted from thin-slice computed tomography (CT) images, and feature selection was performed via the mutual information method and least absolute shrinkage and selection operator regression algorithm. The radiomics (R), FS, and radiomics-frozen section (R-FS) models were established to predict the presence of HGPs in FP. The area under the receiver operating characteristic (ROC) curve, the precision-recall curve, the calibration curve, and decision curve analysis were used to evaluate model performances. The permutation importance algorithm (PIA) and local interpretable model-agnostic explanations (LIME) were used to provide interpretations for the R model. Additionally, the predictive performance was compared among tumors with different CT densities. Results: The R and R-FS models outperformed the FS model, with the R-FS model achieving the best area under the curve value of 0.907 (95% confidence interval: 0.830-0.956) in the test set. PIA and LIME determined the interpretability of outputs from both the overall model and individual sample perspectives. Among the three models, the R model performed best in pure ground-glass nodules and pure-solid tumors. Conclusions: Radiomics could function as a complementary check to FS to provide a more sensible and accurate intraoperative identification of HGPs as compared to the use of FS alone, thus better informing clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.